Cardiovascular Systems (NSDQ:CSII) yesterday revealed that president & CEO David Martin will stay on the job while he undergoes treatment for Stage II stomach cancer.
In a letter to employees, Martin wrote yesterday that his doctors believe his condition is curable.
“My treatment plan is in place and I have begun chemotherapy, with surgery expected later this year. I plan to actively lead our business during my treatment, though some activities, such as travel, will be limited,” Martin wrote.
“Dave is an outstanding leader and has the full support of the board. We wish him a rapid recovery. While he will continue to serve as CEO, Dave has also developed a talented management team that we are confident can lead the company as needed during his treatment and recovery,” added chairman Scott Ward.
